Chronic kidney disease: open trials in Japan

13 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT06278207
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-11-06
NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Trial Treatment · Phase 3 · AstraZeneca
Aira · Amagasaki-shi · Beppu-shi · Chigasaki-shi · Fujinomiya-shi · Hakodate-shi · Hamamatsu · Higashihiroshima-shi · Iizuka-shi · Inashiki-gun · Iwata-shi · Kagoshima · Kamakura-shi · Kanazawa · Kashiwara-shi · Kasugai-shi · Kita-ku · Kitakyushu · Kitakyushu-shi · Kobe · Kumagaya-shi · Kurashiki-shi · Kuse-gun · Kuwana-shi · Kyoto · Matsusaka-shi · Matsuyama · Meguro-ku · Minatoku · Minokamo Shi · Miyakonojo-shi · Morioka · Nagaoka-shi · Naka · Narita-shi · Obihiro-shi · Ōita · Ōme · Ōmihachiman · Osaka · Saga · Sapporo · Sendai · Shibuya-ku · tabashi City · Tanabe-shi · Toyoake-shi · Toyohashi · Tsu · Yaizu-shi · Yokohama · Yoshida-gun
Registry updated 2026-11-06
NCT07241390
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Tokyo-Eki Center-building Clinic, Chūōku · NewHeart Watanabe Institute, Hamadayama, Suginami-ku · Rinku General Medical Center, Izumisano · Kobe City Medical Center General Hospital, Kobe · Yamanashi Prefectural Central Hospital, Kofu · Jinnouchi Hospital, Kumamoto · Yotsuya Internal Medicine Clinic, Shinjuku-ku · Higashi Takarazuka Satoh Hospital, Takarazuka · Uji-Tokushukai Medical Center, Uji · Japanese Red Cross Society - Wakayama Medical Center, Wakayama
Registry updated 2026-11-04
NCT06823115
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Research · Indiana University
Kitasato University School of Medicine, Kanagawa · University of the Ryukyus, Okinawa
Registry updated 2026-10-28
NCT07830719
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Kamakura · Kasugai · Matsubara · Matsudo
Registry updated 2026-10-15
NCT04557462
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Chiba · Kasugai · Kawasaki · Kyoto · Matsumoto · Niigata · Okayama · Ōmihachiman · Osaka · Sapporo · Sendai · Toyoake · Toyota · Yokohama
Registry updated 2026-10-05
NCT07624305
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Trial Treatment · Phase 3 · AstraZeneca
Ageo · Asahi-shi · Chiba · Fukaya · Fukui-shi · Izumisano · Izunokuni-shi · Kariya · Kisarazu-shi · Kita-ku · Kitakyusyu-shi · Kofu · Koga-shi · Komatsu-shi · Koshigaya-shi · Kumagaya-shi · Kumamoto · Kurashiki-shi · Kuwana-shi · Kyoto · Matsumoto-shi · Minamiuonuma · Minatoku · Minokamo Shi · Morioka · Nagoya · Naka · Nerima-ku · Osaka · Sendai · Takatsuki-shi · Toride-shi · Tsu · Urayasu · Yokohama
Registry updated 2026-09-24
NCT05485961
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Trial Treatment · Phase 2/3 · CSL Behring
Matsunami General Hospital, Hashima-gun · Ishikiriseiki Hospital, Higashiosaka-shi · NHO Hiroshimanishi Medical Center, Hiroshima · Miki Internal Medicine Urology Clinic, Hokkaido · University of Tsukuba - Mito Kyodo General Hospital, Ibaraki · Daiyukai Daiichi Hospital, Ichinomiya-shi · Tokyo Medical University Ibaraki Medical Center, Inashiki-gun · Ueyama Hospital, Kagoshima · Ueyama Jin Clinic, Kagoshima · Shonan Kamakura General Hospital, Kamakura-shi · National Hospital Organization Kanazawa Medical Center, Kanazawa · Steel Memorial Yawata Hospital, Kitakyushu-shi · Kokura Memorial Hospital, Kitakyushu-shi · Kurume University Hospital, Kurume · St. Mary's Hospital, Kurume-shi · Omi freai Hospital, Kusatsu-shi · Rakuwakai Otowa Kinen Hospital, Kyoto · Maebashi Hirosegawa Clinic, Maebashi · Joumou Ohashi Clinic, Maebashi · Matsubara Tokushukai Hospital, Matsubara-shi · Nagaoka Red-Cross Hospital, Nagaoka-Shi · Daido Hospital, Nagoya · Chubu Rosai Hospital, Nagoya · Ogaki Tokushukai Hospital, Ogaki-Shi · Omihachiman Community Medical Center - Kidney Center, Ōmihachiman · Oguranaika Jin Cinic, Oyama-shi · Ibaraki Seinan Medical Center Hospital, Sakaimachi · Teine Urological Clinic, Sapporo · Tokyo Womens Med University, Shinjuku-Ku · Kurosawa Hospital, Takasaki-Shi · Kikuchi Medical Clinic, Tsukuba · St.Hill Hospital, Ube-shi · Juntendo University Urayasu Hospital, Urayasu-shi · Yamagata Tokushukai Hospital, Yamagata · Bosei Kannai Clinic, Yokohama · Sanin Rosai Hospital, Yonago-shi
Registry updated 2026-09-21
NCT07753993
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Trial Treatment · Phase 3 · AstraZeneca
Aira · Akita · Asahikawa-shi · Chūōku · Fujisawa-shi · Fukuoka · Hachioji-shi · Hamamatsu · Hiroshima · Ichikawa-shi · Ina-shi · Iruma-Gun · Izunokuni-shi · Kamakura-shi · Kamiina-gun · Kanazawa · Kasugai-shi · Kasuga-shi · Kawachinagano-shi · Kitakyushu · Kitakyushu-shi · Kumamoto · Kurume · Kuwana-shi · Matsumoto-shi · Minatoku · Minokamo Shi · Moriyama-shi · Nagoya · Naka · Ōita · Okayama · Osaka · Oyama-shi · Sakaishi · Sakushu · Sapporo · Sasebo-shi · Shinjuku-ku · Suita-shi · Suwa-shi · Takasago-shi · Tsu · Ueda-shi · Ushiku-shi · Utsunomiya · Yokohama
Registry updated 2026-09-09
NCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Trial Treatment · Phase 3 · AstraZeneca
Chigasaki-shi · Chikushino-shi · Gifu · Kagoshima · Kitakyushu · Kumamoto · Kyoto · Maebashi · Nagoya · Osaka · Sapporo · Suita-shi · Tachikawa-shi · Toyota-Shi
Registry updated 2026-09-02
NCT07619157
A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus
Trial Treatment · Phase 1 · Ono Pharmaceutical Co., Ltd.
Souseikai Hakata Clinic, Fukuoka
Registry updated 2026-06-08
NCT06717698
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Trial Treatment · Phase 2 · Novo Nordisk A/S
TOSAKI Clinic for Diabetes and Endocrinology_Diabetes and Endocrinology, Aichi · Naka Kinen Clinic_Internal medicine, Ibaraki · Fujisawa City Hospital_Kidney internal medicine, Kanagawa · Higashijujo Sakai Diabetes Clinic_Internal Medicine, Kita-ku, Tokyo · Seino Internal Medicine Clinic_Internal medicine, Koriyama-shi, Fukushima · Koshigaya Municipal Hospital_Internal medicine, Saitama · Hanyu General Hospital_Internal Medicine, Saitama · Shinden Higashi Clinic, Sendai-shi, Miyagi · Shinden Higashi Clinic_Internal medicine, Sendai-shi, Miyagi · Omihachiman Community Medical Center_Nephrology, Siga · Fukuwa Clinic, Tokyo · Tokyo-Eki Center-building Clinic_Internal Medicine, Tokyo · Kato Clinic of Internal Medicine, Tokyo · Fukuwa Clinic_Internal Medicine, Tokyo · Kato Clinic of Internal Medicine_Internal Medicine, Tokyo
Registry updated 2026-03-11
NCT06694012
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Research · Osaka Metropolitan University
The Ohtori Health Promotion Center, Sakai
Registry updated 2024-12-04

All Chronic kidney disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error